ADVERTISEMENT
Posted: Jul 7, 2024

Rethinking ß-blockers after myocardial infarction in patients with preserved ejection fraction

Heart Health

The long-term use of ß-blockers in patients with acute myocardial infarction (MI) who undergo early coronary angiography and have a preserved left ventricular ejection fraction may not lower the risk of death or a new MI as previously believed, revealed a study published in the April 18, 2024, issue of NEJM.

Lauren Howell, PharmD
 

Read more
Posted: Jul 7, 2024

The elevated—and often hidden—risk of CVD and T1D

Diabetes

An April 4, 2024, review article in NEJM noted that patients with T1D are facing an added medical challenge: the increased risk of CVD that accompanies a T1D diagnosis. 

Elizabeth Briand

Read more
Posted: Jul 7, 2024

Pharmacotherapy could decrease mortality in patients with ADHD

ADHD

Most pharmacists were taught that ADHD is associated with increased risks of adverse health outcomes, including premature death.

Lauren Howell, PharmD

Read more
Posted: Jul 7, 2024

What is food pharmacy?

Health Equity

Patients who come into a clinic at San Francisco Health Network (SFHN) can see fresh food displayed in a designated area.

Loren Bonner

Read more
Posted: Jul 7, 2024

New and Approved

Updates from FDA

Updates from FDA

Read more
12

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT